Found 90 matching trials
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies
PHASE1The primary purpose of this study is to determine the safety and efficacy o...
Location
The Affiliated People's Hospital of Ningbo University
IL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell Leukemia
PHASE2This is an open-label, single-arm, Phase 2 study to evaluate the efficacy a...
Location
The First Hospital of Jilin University
UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases
EARLY_PHASE1This is a single-arm, open-label, investigator-initiated trial (IIT) design...
Location
Union Hospital, Tongji Medical College, Huazhong University of Science & Technology
Universal CAR-T Cells Targeting Multiple Myeloma
PHASE1The aim of this study is to assess the feasibility, safety and efficacy of ...
Location
Shenzhen Geno-Immune Medical Institute
CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Transplant Participants
EARLY_PHASE1The purpose of this study is to assess the safety, tolerability, and effica...
Location
Tongji Hospital, Tongji Medical Collage of Huazhong University of Science & Technology
CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH
PHASE1This is a single-center, open-label, non-randomized, single-arm clinical tr...
Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
PHASE1This is an open, single-arm, clinical study to evaluate the efficacy and sa...
Location
District One Hospital
Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.
PHASE1This is a single-center, open-label, non-randomized, single-arm clinical tr...
Location
Beijing GoBroad Hospital
Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease
PHASE2The goal of this clinical trial is to test the safety and potential benefit...
Location
Department of Rheumatology and Immunology, the First Medical Center, Chinese PLA General Hospital
Autoimmune Disease Treatment With Mesenchymal Stem Cells (MSCs) and CAR-T Cells
PHASE1The purpose of this study is to assess the feasibility, safety and efficacy...
Location
Shenzhen Geno-immune Medical Institute